1. |
Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis [J]. JAMA, 2003; 289(22): 30003004.
|
2. |
Brunt EM. Nonalcoholic steatohepatitis: definition and pathology [J]. Semin Liver Dis, 2001; 21(1): 316.
|
3. |
Bravo AA, Sheth SG, Chopra S. Liver biopsy [J]. N Engl J Med , 2001; 344(7): 495500.
|
4. |
Siegelman ES, Mitchell DG, Semelka RC. Abdominal iron deposition: metabolism, MR findings, and clinical importance [J]. Radiology, 1996; 199(1): 1322.
|
5. |
Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis [J]. J Hepatol, 2000; 33(3): 485504.
|
6. |
Brissot P, Bourel M, Herry D, et al. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods [J]. Gastroenterology, 1981; 80(3): 557565.
|
7. |
Abenoza P, Sibley RK. Farber’s disease: a fine structural study [J]. Ultrastruct Pathol, 1987; 11(4): 397403.
|
8. |
Ros PR, Ji H. Special focus session: multisection (multidetector) CT: applications in the abdomen [J]. Radiographics, 2002; 22(3): 697700.
|
9. |
Raptopoulos V, Karellas A, Bernstein J, et al. Value of dualenergy CT in differentiating focal fatty infiltration of the liver from lowdensity masses [J]. AJR Am J Roentgenol, 1991; 157(4): 721725.
|
10. |
Hamer OW, Aguirre DA, Casola G, et al. Imaging features of perivascular fatty infiltration of the liver: initial observations [J]. Radiology, 2005; 237(1): 159169.
|
11. |
Guyader D, Gandon Y, Deugnier Y, et al. Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis [J]. Gastroenterology, 1989; 97(3): 737743.
|
12. |
Howard JM, Ghent CN, Carey LS, et al. Diagnostic efficacy of hepatic computed tomography in the detection of body iron overload [J]. Gastroenterology, 1983; 84(2): 209215.
|
13. |
Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: quantification with phasecontrast MR imaging at 1.5 T vs biopsy [J]. AJR Am J Roentgenol, 1991; 156(2): 307312.
|
14. |
KatzBrull R, Rofsky NM, Lenkinski RE. Breathhold abdominal and thoracic proton MR spectroscopy at 3 T [J]. Magn Reson Med, 2003; 50(3): 461467.
|
15. |
Chmelík M, Schmid AI, Gruber S, et al. Threedimensional highresolution magnetic resonance spectroscopic imaging for absolute quantification of 31P metabolites in human liver [J]. Magn Reson Med, 2008; 60(4): 796802.
|
16. |
Kim YK, Kim CS, Lee YH, et al. Comparison of superparamagnetic iron oxideenhanced and gadobenate dimeglumineenhanced dynamic MRI for detection of small hepatocellular carcinomas [J]. AJR Am J Roentgenol, 2004; 182(5): 12171223.
|
17. |
王秋实, 郭启勇, 梁长虹, 等. MR弥散加权成像评价肝纤维化的初步实验研究 [J]. 解剖学研究, 2007; 29(3): 212216.
|
18. |
管生, 赵卫东, 周康荣, 等. 磁共振弥散功能成像对肝脏早期弥漫性病变诊断价值的试验研究 [J]. 中华肝病杂志, 2005; 13(7): 524527.
|
19. |
Xu L, Gao PY. “Palpation by imaging”: magnetic resonance elastography [J]. Chin Med Sci J, 2006; 21(4): 281286.
|
20. |
Cobbold JF, Morin S, TaylorRobinson SD. Transient elastography for the assessment of chronic liver disease: ready for the clinic? [J]. World J Gastroenterology, 2007; 13(36): 47914797.
|
21. |
Garbow JR, Lin X, Sakata N, et al. In vivo MRS measurement of liver lipid levels in mice [J]. J Lipid Res, 2004; 45(7): 13641371.
|
22. |
Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study [J]. Gut, 2005; 54(1): 122127.
|
23. |
Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population [J]. Am J Physiol Endocrinol Metab, 2005; 288(2): E462 E468.
|
24. |
Alústiza JM, Artetxe J, Castiella A, et al. MR quantification of hepatic iron concentration [J]. Radiology, 2004; 230(2): 479484.
|
25. |
Westphalen AC, Qayyum A, Yeh BM, et al. Liver fat: effect of hepatic iron deposition on evaluation with opposedphase MR imaging [J]. Radiology, 2007; 242(2): 450455.
|
26. |
Gandon Y, Olivié D, Guyader D, et al. Noninvasive assessment of hepatic iron stores by MRI [J]. Lancet, 2004; 363(9406): 357362.
|
27. |
Andrews NC. Disorders of iron metabolism [J]. N Engl J Med, 1999; 341(26): 19861995.
|
28. |
Horton KM, Bluemke DA, Hruban RH, et al. CT and MR imaging of benign hepatic and biliary tumors [J]. Radiographics, 1999; 19(2): 431451.
|
29. |
Lorigan JG, Charnsangavej C, Carrasco CH, et al. Atrophy with compensatory hypertrophy of the liver in hepatic neoplasms: radiographic findings [J]. AJR Am J Roentgenol, 1988; 150(6): 12911295.
|
30. |
Mathieu D, Vasile N, Menu Y, et al. BuddChiari syndrome: dynamic CT [J]. Radiology, 1987; 165(2): 409413.
|
31. |
Kawamoto S, Soyer PA, Fishman EK, et al. Nonneoplastic liver disease: evaluation with CT and MR imaging [J]. Radiographics, 1998; 18(4): 827848.
|
32. |
Proujansky R, Vinton N. Acute hepatitis [J]. Adolesc Med, 1995; 6(3): 437446.
|
33. |
Semelka RC, Kelekis NL, Sallah S, et al. Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging [J]. AJR Am J Roentgenol, 1997; 169(5): 13111316.
|
34. |
Sallah S, Semelka RC, Wehbie R, et al. Hepatosplenic candidiasis in patients with acute leukaemia [J]. Br J Haematol, 1999; 106(3): 697701.
|
35. |
Thanos L, Zormpala A, Brountzos E, et al. Nodular hepatic and splenic sarcoidosis in a patient with normal chest radiograph [J]. Eur J Radiol, 2002; 41(1): 1011.
|
36. |
Sakai T, Maeda M, Takabatake M, et al. MR imaging of hepatosplenic sarcoidosis [J]. Radiat Med, 1995; 13(1): 3941.
|